BRKR peer analysis
Bruker (BRKR) against its competitors: price, today's move, 1-year return and market value side by side.
BRKR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| A Agilent | $171.96 | -1.66% | 19.95% | – |
| BIO Bio-Rad | $366.21 | -1.60% | 20.22% | $9.95B |
| DHR Danaher | $228.11 | -1.77% | 6.07% | $163.25B |
| MTD Mettler-Toledo | $1,680.55 | 0.34% | 22.04% | $33.56B |
| PACB Pacific Biosciences | $2.34 | -9.98% | 20.88% | $809.71M |
| QGEN QIAGEN | $50.12 | -0.20% | 8.18% | $10.37B |
| RVTY Revvity | $151.70 | -3.38% | 66.67% | – |
| TECH Bio-Techne | $72.68 | 0.03% | 19.23% | $11.41B |
| TMO Thermo Fisher | $682.81 | -2.04% | 22.76% | $257.71B |
| WAT Waters | $448.74 | -3.02% | 30.87% | $45.46B |
| BRKR Bruker | $55.67 | -2.44% | 52.95% | $8.70B |
- BRKR's peers: A (Agilent), BIO (Bio-Rad), DHR (Danaher), MTD (Mettler-Toledo), PACB (Pacific Biosciences), QGEN (QIAGEN), RVTY (Revvity), TECH (Bio-Techne).
Updated 2026-11-02 23:14 UTC